Nathan R McGee Selected Research

Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)

1/2018	Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
1/2018	Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.
1/2014	CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.
10/2013	CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive.
5/2013	CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.
3/2013	Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders.
2/2012	Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan R McGee Research Topics

Disease

7	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018 - 02/2012
4	Nervous System Diseases (Neurological Disorders) 10/2017 - 09/2013
4	Neuroinflammatory Diseases 10/2017 - 01/2013
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Gliosis 01/2014

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2018 - 03/2013
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2014
3	ChemokinesIBA 01/2018 - 05/2013
1	Rituximab (Mabthera)FDA Link 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Oligoclonal BandsIBA 01/2018
1	Lipopolysaccharide ReceptorsIBA 10/2017
1	SteroidsIBA 10/2013
1	Chemotactic FactorsIBA 02/2012

Therapy/Procedure

4	Immunotherapy 01/2018 - 01/2013
1	Therapeutics 05/2013